Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 January 2023 to Question 119098, on Breast Cancer: Chemotherapy, when NICE will publish its decision on whether the guidance on tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer will be updated following the 2021 review.

Following a review of its diagnostics guidance on tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer [DG34], the National Institute for Health and Care Excellence (NICE) has confirmed that an update of its guidance on tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer [DG34] is in the very early stages of development.

Further information will be made available on NICE’s website as development of the updated guidance progresses.